PRTA
Prothena Corporation PLC
Price:  
10.04 
USD
Volume:  
410,329.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA Relative Valuation

-776.3%
Upside

As of 2026-04-07, the Relative Valuation of Prothena Corporation PLC (PRTA) is (67.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.04 USD, the upside of Prothena Corporation PLC based on Relative Valuation is -776.3%.

The range of the Relative Valuation is (50.06) - (85.97) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.8x - 20.1x 15.0x
Forward P/E multiples 11.0x - 19.0x 15.0x
Fair Price (50.06) - (85.97) (67.90)
Upside -598.6% - -956.3% -776.3%
10.04 USD
Stock Price
(67.90) USD
Fair Price

PRTA Relative Valuation - Historical P/E Data

Date P/E
2026-04-06 -2.20
2026-04-02 -2.17
2026-04-01 -2.21
2026-03-31 -2.14
2026-03-30 -2.04
2026-03-27 -2.04
2026-03-26 -2.10
2026-03-25 -2.05
2026-03-24 -1.93
2026-03-23 -1.95
2026-03-20 -1.93
2026-03-19 -1.88
2026-03-18 -1.89
2026-03-17 -1.98
2026-03-16 -2.02
2026-03-13 -2.03
2026-03-12 -2.05
2026-03-11 -2.11
2026-03-10 -2.15
2026-03-09 -2.16
2026-03-06 -2.11
2026-03-05 -2.09
2026-03-04 -2.17
2026-03-03 -2.06
2026-03-02 -2.07
2026-02-27 -1.91
2026-02-26 -1.91
2026-02-25 -1.96
2026-02-24 -1.98
2026-02-23 -2.00
2026-02-20 -1.99
2026-02-19 -1.99
2026-02-18 -2.00
2026-02-17 -1.98
2026-02-13 -1.98
2026-02-12 -1.95
2026-02-11 -1.97
2026-02-10 -1.98
2026-02-09 -1.95
2026-02-06 -1.96
2026-02-05 -1.84
2026-02-04 -1.96
2026-02-03 -1.94
2026-02-02 -1.96
2026-01-30 -1.94
2026-01-29 -2.00
2026-01-28 -2.02
2026-01-27 -2.15
2026-01-26 -2.19
2026-01-23 -2.21